Experimental cancer vaccine shows promise in preventing cancer in high-risk patients

An investigational cancer vaccine, NOUS-209, has demonstrated encouraging early results in stimulating anti-tumor immunity in individuals with Lynch Syndrome (LS), a hereditary…

Studies link tumor bacteria to immunotherapy resistance in head and neck cancer

Two studies published simultaneously in Nature Cancer have identified elevated levels of bacteria within tumors as a major factor contributing to immune…

Researchers discover drug combination that could overcome neuroblastoma resistance

Australian scientists have uncovered a promising new approach to treat neuroblastoma, a childhood cancer that currently claims nine…

New study highlights growing promise of routine blood tests in breast cancer detection and management

Breast cancer remains one of the leading health threats faced by women around the world, with…

Novel radioimmunotherapy achieves histologic cures in HER2-positive breast cancer, new study finds

In groundbreaking research published in the November issue of The Journal of Nuclear Medicine, scientists report…

John’s Hopkins scientists report breakthrough in pancreatic cancer treatment using targeted intraoperative radiation

In a landmark development, scientists at the Johns Hopkins Kimmel Cancer Center have achieved a 95%…

Study links poor air quality to increased breast cancer risk, major US study finds

A new multiyear investigation published in the American Journal of Public Health has revealed that women…

New study shows osimertinib plus chemotherapy improves survival in EGFR-mutated lung cancer

A landmark international Phase 3 trial published in The New England Journal of Medicine has demonstrated…

NIH study links hormone therapy types to breast cancer risk in women under 55 years

A landmark study published in The Lancet Oncology by scientists at the National Institutes of Health…

Biweekly dosing of trifluridine-tipiracil shows promise in improving tolerability without compromising efficacy in advanced colorectal cancer

A new retrospective study published in The Oncologist reports that a biweekly dosing schedule of trifluridine-tipiracil…

Don’t miss our updates!

We don’t spam! Read our [link]privacy policy[/link] for more info.